peptron
  • About Peptron
    • Company
    • History
    • Organization
    • Corporate Governance
    • PR Videos
  • Technology
    • About Long acting
    • SmartDepot¢â
  • Pipeline
    • Pipeline
    • PT320
    • PAb 001
  • Partnering
    • Focusing areas
    • Collaboration
    • Development process
    • Manufacturing with GMP
  • Investor
    • Presentation/IR*
  • Contact Us
    • Location
    • Peptide Synthesis Service
  • About Peptron
    • Company
    • History
    • Organization
    • Corporate Governance
  • Technology
    • About Long acting
    • SmartDepot¢â
  • Pipeline
    • Pipeline
    • PT320
    • PAb 001
  • Partnering
    • Focusing areas
    • Collaboration
    • Development process
    • Manufacturing with GMP
  • Investor
    • Presentation/IR*
  • Contact us
    • Location
    • Peptide Synthesis Service
  • Sustained Release Medication
    with GMP facility

    In Apr 2018, Peptron established own manufacturing facility in Osong, Korea, which can produce over 48,000 vials of SR-exenatide per month. All manufacturing equipment and process are designed and installed under GMP guideline. To get appropriate GMP certification, preparation of related GMP regulatory pathway and application process are on-going.

    Read more

  • CNS medication
    with new mechanism

    In 2014, Peptron has exclusively licensed in the NIH patents which allows only Peptron to develop exenatide as drug for neurodegenerative disorders and both NIH and Peptron have been collaborating additional research.

    Read more

  • SmartDepot

    SmartDepot¢â is Peptron¡¯s proprietary ultrasonic spray drying technology for the preparation of sustained release (SR) injectable microsphere formulation of drug. Recently, this long-acting technology has attracted the intense attention of global pharmaceutical companies since the costs for developing new medicines are soaring and patent expirations of many blockbuster drugs are just around the corner.

    Read more

  • About Long acting

    long-acting technologies may offer controlled drug-release profile...

  • Pipeline

    PT320
    PAb 001..

  • Partnering

    Peptron is looking for collaboration partners who have proprietary...

  • PR Videos

    You can see a promotional video of peptron...

peptron

37-24, Yuseong-daero 1628 beon-gil, Yuseong-gu, Daejeon, 34054, Republic of Korea TEL +82-42-360-8880 / FAX +82-42-360-8888 /
E-Mail : biz@peptron.com

COPYRIGHT ¨Ï Peptron ALL RIGHTS RESERVED.